Osteoarthritis, KneeEXERPHARMANCT01638962
The Effect on Knee Joint Loads of Analgesic Use Compared With Exercise in Patients With Knee Osteoarthritis - An RCT
A study testing Instruction on analgesic use for pain relief (acetaminophen and NSAIDs) and Neuromuscular exercise in people with Osteoarthritis, Knee, run by University of Southern Denmark at 1 site in Denmark.
Trial summary
The purpose of this study is to compare the effects of neuromuscular exercise and analgesic use on knee joint load, in patients with mild to moderate knee osteoarthritis (OA). It is expected that the two groups will receive equipotent pain relieving effect, despite this, the investigators expect a between group… Read more about this study
- Who is it for?
- Ages 40 to 70 years
- Conditions the study is for
- Osteoarthritis, Knee
- What is being tested?
- Instruction on analgesic use for pain relief (acetaminophen and NSAIDs) and Neuromuscular exercise
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 93 participants
- Where
- 1 siteDenmark
- Study dates
- Aug 2012to Jul 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Compliance with the ACR criteria
- Medial knee OA defined as "No osteoarthritis", "Doubtful narrowing of joint space and/or possible osteophytes", "Definite osteophytes and possible narrowing of joint space", "Multiple osteophytes, definite narrowing of joint space and some sclerosis and deformity of bone ends". This corresponds to the Kellgren and Lawrence (KL) grades 0, 1, 2 and 3 respectively
- Willingness to participate in exercise and use of analgesics
- A maximum of 75/100 points in the KOOS Pain subscale
- BMI of 32 or less
Who cannot join
- Medial greater than lateral joint space width
- Medial knee OA of KL grade 4
- Knee surgery or steroid injection within the past 6 months
- Already taking max dose NSAIDs or acetaminophen
- Any physician-determined condition that is a contraindication for use of acetaminophen, NSAIDs or to exercise
- Problems affecting the lower extremity overriding the problems from the knee
Show all 15Show fewer
- Knee surgery planned in the next 6 months
- Known ACL tear within the past 6 months
- ACL reconstruction
- Diagnosis of systemic arthritis
- Difficulty complying with treatment schedule
- Inability to fill out questionnaires
- Inability to ambulate without an assistive device
- Ankle, knee or hip replacement
- Tibial/femoral osteotomy
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect on Knee Joint Loads of Instruction in Analgesic Use Compared With NEUROMUSCULAR Exercise in Patients With Knee Osteoarthritis - A Single Blind RCT
The purpose of this study is to compare the effects of neuromuscular exercise and analgesic use on knee joint load, in patients with mild to moderate knee osteoarthritis (OA).
It is expected that the two groups will receive equipotent pain relieving effect, despite this, the investigators expect a between group difference in knee joint load, and the exercise group will have a reduction in knee joint load.
- Conditions
- Osteoarthritis, Knee
- Being tested
- Instruction on analgesic use for pain relief (acetaminophen and NSAIDs), Neuromuscular exercise
- Keywords
- Exercise Therapy, Gait, Joint load, Knee Joint, Middle Aged, Osteoarthritis, Knee/therapy, Pain Management
- Medical subject headings
- Osteoarthritis, Knee, Osteoarthritis, Agnosia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Instruction on analgesic use for pain relief (acetaminophen and NSAIDs)Drug
Also called Acetaminophen, Non-Steroid Anti-Inflamatoric Drug:, Ibuprofen, Acetylsalicylic acid
The PHARMA group receives instruction, by video and pamphlet, on how to best use acetaminophen and NSAID as pain management for knee OA.
Neuromuscular exerciseOther
Also called Exercise, Stability, Alignment, Functional
The exercise group receives 1 hour of supervised neuromuscular exercise two times a week for 8 weeks. Supervision is conducted by physiotherapists specially trained in using neuromuscular exercise and its principles.
| Study group | Role | What they receive |
|---|---|---|
| NEMEX | Experimental | NEuroMuscular EXercise Receives: Other: Neuromuscular exercise |
| PHARMA | Active comparator | PHARMAcological pain relief Receives: Drug: Instruction on analgesic use for pain relief (acetaminophen and NSAIDs) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline in 1st peak RMS (root mean square) Knee Index.
1st peak RMS Knee Index, is combined of the moments of the 3 planes working over the the knee; flexion, adduction and internal rotation moments. Measured with the Vicon system.
1st peak RMS knee moment = √(Kflex. moment2 + Kadd. moment2 + Kint.rot. moment2 )/3
Measured: Baseline and post intervention (8 weeks)
Secondary outcomes (5)
Change from baseline in 1st peak Knee adduction moment
Measured: Baseline and post intervention (8 weeks)
Change from baseline in the KOOS (Knee injury and Osteoarthritis Outcome Score) questionnaire
Measured: Baseline and post intervention (8 weeks)
Change from baseline in Maximum number of one-leg rises from stool test
This test evaluates maximal performance and muscle strength in the lower extremity
Measured: Baseline and post intervention (8 weeks)
Change from baseline in Maximum number of knee-bendings in 30s test
This test evaluates the ability to perform fast changes between eccentric and concentric muscle force over the knee joint
Measured: Baseline and post intervention (8 weeks)
Change from baseline in One-leg hop for distance test
The test mimics sporting activities and demands muscle explosivety, balance and functional stability of the knee
Measured: Baseline and post intervention (8 weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jul 2012 (estimated)
- Study startAug 2012
- Primary completionAug 2015
- Study completionJul 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Osteoarthritis, KneeStudies of the same condition, open and under way.
- More trials run by University of Southern DenmarkThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 93 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Southern Denmark
- Sponsor type
- University, hospital or other
- Collaborators
- Odense University Hospital, Region Syddanmark, The Danish Rheumatism Association, Association of Danish Physiotherapists
- Responsible party
- Principal investigator, Brian Clausen, University of Southern Denmark
- Investigators
- Brian Clausen, PT, M.Sc., Principal investigator, Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern DenmarkEwa M. Roos, Professor, Study chair, Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01638962
- Sponsor's protocol ID
- S-20110153
- Acronym
- EXERPHARMA
- Status last verified
- Aug 2016
- First submitted
- 3 Jul 2012
- Last updated
- 3 Aug 2016
- Results posted
- No
- Data monitoring committee
- No
Publications
Thorstensson CA, Henriksson M, von Porat A, Sjodahl C, Roos EM. The effect of eight weeks of exercise on knee adduction moment in early knee osteoarthritis--a pilot study. Osteoarthritis Cartilage. 2007 Oct;15(10):1163-70. doi: 10.1016/j.joca.2007.03.012. Epub 2007 Apr 26.
PubMed 17466541Ageberg E, Link A, Roos EM. Feasibility of neuromuscular training in patients with severe hip or knee OA: the individualized goal-based NEMEX-TJR training program. BMC Musculoskelet Disord. 2010 Jun 17;11:126. doi: 10.1186/1471-2474-11-126.
PubMed 20565735Holsgaard-Larsen A, Christensen R, Clausen B, Sondergaard J, Andriacchi TP, Roos EM. One year effectiveness of neuromuscular exercise compared with instruction in analgesic use on knee function in patients with early knee osteoarthritis: the EXERPHARMA randomized trial. Osteoarthritis Cartilage. 2018 Jan;26(1):28-33. doi: 10.1016/j.joca.2017.10.015. Epub 2017 Oct 26.
PubMed 29107059Holsgaard-Larsen A, Clausen B, Sondergaard J, Christensen R, Andriacchi TP, Roos EM. The effect of instruction in analgesic use compared with neuromuscular exercise on knee-joint load in patients with knee osteoarthritis: a randomized, single-blind, controlled trial. Osteoarthritis Cartilage. 2017 Apr;25(4):470-480. doi: 10.1016/j.joca.2016.10.022. Epub 2016 Nov 9.
PubMed 27836677Clausen B, Holsgaard-Larsen A, Sondergaard J, Christensen R, Andriacchi TP, Roos EM. The effect on knee-joint load of instruction in analgesic use compared with neuromuscular exercise in patients with knee osteoarthritis: study protocol for a randomized, single-blind, controlled trial (the EXERPHARMA trial). Trials. 2014 Nov 15;15:444. doi: 10.1186/1745-6215-15-444.
PubMed 25399048
Study at a glance
From the registry record, last updated by the sponsor on 3 Aug 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect on Knee Joint Loads of Instruction in Analgesic Use Compared With NEUROMUSCULAR Exercise in Patients With Knee Osteoarthritis - A Single Blind RCT
- ClinicalTrials.gov ID
- NCT01638962
- Acronym / sponsor ID
- EXERPHARMA / S-20110153
- Conditions
- Osteoarthritis, Knee
- Keywords
- Exercise Therapy, Gait, Joint load, Knee Joint, Middle Aged, Osteoarthritis, Knee/therapy, Pain Management
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 93 participants (actual)
- Lead sponsor
- University of Southern DenmarkUniversity, hospital or other
- Collaborators
- Odense University Hospital, Region Syddanmark, The Danish Rheumatism Association, Association of Danish Physiotherapists
- Study start
- Aug 2012
- Primary completion
- Aug 2015 (actual)
- Study completion
- Jul 2016 (actual)
- First posted
- 12 Jul 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to compare the effects of neuromuscular exercise and analgesic use on knee joint load, in patients with mild to moderate knee osteoarthritis (OA).
It is expected that the two groups will receive equipotent pain relieving effect, despite this, the investigators expect a between group difference in knee joint load, and the exercise group will have a reduction in knee joint load.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| NEMEX | Experimental | Other: Neuromuscular exerciseNEuroMuscular EXercise |
| PHARMA | Active comparator | Drug: Instruction on analgesic use for pain relief (acetaminophen and NSAIDs)PHARMAcological pain relief |
Who may qualify
- Ages
- 40 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Compliance with the ACR criteria
- Medial knee OA defined as "No osteoarthritis", "Doubtful narrowing of joint space and/or possible osteophytes", "Definite osteophytes and possible narrowing of joint space", "Multiple osteophytes, definite narrowing of joint space and some sclerosis and deformity of bone ends". This corresponds to the Kellgren and Lawrence (KL) grades 0, 1, 2 and 3 respectively
- Willingness to participate in exercise and use of analgesics
- A maximum of 75/100 points in the KOOS Pain subscale
- BMI of 32 or less
Key exclusion criteria (15 listed)
- Medial greater than lateral joint space width
- Medial knee OA of KL grade 4
- Knee surgery or steroid injection within the past 6 months
- Already taking max dose NSAIDs or acetaminophen
- Any physician-determined condition that is a contraindication for use of acetaminophen, NSAIDs or to exercise
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Instruction on analgesic use for pain relief (acetaminophen and NSAIDs)Also: Acetaminophen, Non-Steroid Anti-Inflamatoric Drug:, Ibuprofen, Acetylsalicylic acidThe PHARMA group receives instruction, by video and pamphlet, on how to best use acetaminophen and NSAID as pain management for knee OA. | Drug | PHARMA |
| Neuromuscular exerciseAlso: Exercise, Stability, Alignment, FunctionalThe exercise group receives 1 hour of supervised neuromuscular exercise two times a week for 8 weeks. Supervision is conducted by physiotherapists specially trained in using neuromuscular exercise and its principles. | Other | NEMEX |
Primary outcome
Change from baseline in 1st peak RMS (root mean square) Knee Index.
Time frame: Baseline and post intervention (8 weeks)
1st peak RMS Knee Index, is combined of the moments of the 3 planes working over the the knee; flexion, adduction and internal rotation moments. Measured with the Vicon system. 1st peak RMS knee moment = √(Kflex. moment2 + Kadd. moment2 + Kint.rot. moment2 )/3
5 secondary outcomes
Change from baseline in 1st peak Knee adduction moment
Time frame: Baseline and post intervention (8 weeks)
Change from baseline in the KOOS (Knee injury and Osteoarthritis Outcome Score) questionnaire
Time frame: Baseline and post intervention (8 weeks)
Change from baseline in Maximum number of one-leg rises from stool test
Time frame: Baseline and post intervention (8 weeks)
Change from baseline in Maximum number of knee-bendings in 30s test
Time frame: Baseline and post intervention (8 weeks)
Change from baseline in One-leg hop for distance test
Time frame: Baseline and post intervention (8 weeks)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Aug 2016.
- Background: PubMed 17466541Thorstensson CA, Henriksson M, von Porat A, Sjodahl C, Roos EM. The effect of eight weeks of exercise on knee adduction moment in early knee osteoarthritis--a pilot study. Osteoarthritis Cartilage. 2007 Oct;15(10):1163-70. doi: 10.1016/j.joca.2007.03.012. Epub 2007 Apr 26.
- Background: PubMed 20565735Ageberg E, Link A, Roos EM. Feasibility of neuromuscular training in patients with severe hip or knee OA: the individualized goal-based NEMEX-TJR training program. BMC Musculoskelet Disord. 2010 Jun 17;11:126. doi: 10.1186/1471-2474-11-126.
- Derived from this study: PubMed 29107059Holsgaard-Larsen A, Christensen R, Clausen B, Sondergaard J, Andriacchi TP, Roos EM. One year effectiveness of neuromuscular exercise compared with instruction in analgesic use on knee function in patients with early knee osteoarthritis: the EXERPHARMA randomized trial. Osteoarthritis Cartilage. 2018 Jan;26(1):28-33. doi: 10.1016/j.joca.2017.10.015. Epub 2017 Oct 26.
- Derived from this study: PubMed 27836677Holsgaard-Larsen A, Clausen B, Sondergaard J, Christensen R, Andriacchi TP, Roos EM. The effect of instruction in analgesic use compared with neuromuscular exercise on knee-joint load in patients with knee osteoarthritis: a randomized, single-blind, controlled trial. Osteoarthritis Cartilage. 2017 Apr;25(4):470-480. doi: 10.1016/j.joca.2016.10.022. Epub 2016 Nov 9.
- Derived from this study: PubMed 25399048Clausen B, Holsgaard-Larsen A, Sondergaard J, Christensen R, Andriacchi TP, Roos EM. The effect on knee-joint load of instruction in analgesic use compared with neuromuscular exercise in patients with knee osteoarthritis: study protocol for a randomized, single-blind, controlled trial (the EXERPHARMA trial). Trials. 2014 Nov 15;15:444. doi: 10.1186/1745-6215-15-444.
Related trials for Osteoarthritis, Knee
Not yet recruitingPhase 2
PPV-06 Vaccine in Inflammatory Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
Boosting Exercise Adherence in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
Tempo-controlled Low-load Resistance Training in Patients With Knee Osteoarthritis.
Knee Osteoarthritis
Not yet recruiting
Opioid Reduction and Enhanced Recovery in Orthopaedic Surgery (OREOS)-Knee
Knee Arthroplasty, Total, Partial Knee Arthroplasty
Active, not recruiting
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
Osteo Arthritis Knee, Joint Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Brian Clausen, PT, M.Sc. principal investigator
Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark
Ewa M. Roos, Professor study chair
Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Instruction on analgesic use for pain relief (acetaminophen and NSAIDs) and Neuromuscular exercise in people with Osteoarthritis, Knee, run by University of Southern Denmark at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline in 1st peak RMS (root mean square) Knee Index. (time frame: Baseline and post intervention (8 weeks)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01638962, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2016.